-
From "Market Blindness" to "Investor Magnet": Korean PropTech Game Changer Wins Over 50 Clients Including GIC and DWS in Just 8 Months
SEOUL, South Korea, Aug. 21, 2025 -- Korean PropTech startup RSQUARE's RA (Rsquare Analytics) solution is reshaping how global investors view the Korean commercial real estate market. Until recently the market forced multi-million-dollar investment decisions to be made with limited transparency. Investors had to contact dozens of brokers or rely on personal networks to obtain even basic data such as prime office rent or vacancy rates. The information gathered was often inconsistent, keeping foreign capital away for decades. In 2023 RSQUARE launched RA, a platform recognized as a
- 황정호 기자
- 2025-08-21 20:00
-
SK bioscience Discusses Further Collaboration with the Gates Foundation to Advance Global Health
Company holds a dedicated meeting with Gates Foundation executives during Bill Gates' visit to Korea. Both reviews expanded cooperation, including next-generation preventive medicines. SEONGNAM, South Korea, Aug. 21, 2025 -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that the company held an exclusive meeting with the Gates Foundation in line with the visit of Bill Gates, Founder and Chair of the Foundation, to Korea to discuss ways to advance global health collaboration.&nbs
- 김갑성 기자
- 2025-08-21 20:00
-
BioDlink's Bevacizumab Approved for Market Launch in Indonesia, Marking Fourth Consecutive Emerging Market Authorization
Bevacizumab Injection officially approved by Indonesia's National Agency of Drug and Food Control (BPOM), following Nigeria, Pakistan, and Colombia – accelerating global commercialization Approval in ASEAN's largest pharma market strengthens BioDlink's position as a global supplier of antibody/XDC therapies via international GMP standards and commercial capabilities SUZHOU, China, Aug. 21, 2025 -- BioDlink announced that its Bevacizumab Injection has obtained marketing authorization from Indonesia's National Agency of Drug and Food Control (BPOM). This mark
- 김갑성 기자
- 2025-08-21 20:00
-
FDA clearance of Salix® Coronary Plaque module
[ 메디채널 김갑성 기자 ] Significantly expands U.S. commercial opportunity with ability to charge fees per scan assessed Investor Webinar - 11.30am AEST (9.30am AWST) on 22 August 2025 PERTH, Australia, Aug. 21, 2025 -- Artrya Limited (ASX: AYA) (Artrya or the Company), a medical technology company commercialising its Salix® AI-powered cloud platform, for the near real time, point of care assessment and management of coronary artery disease, is pleased to announce it has received 510(k) clearance from the U.S. Food and Drug Administration (the FDA) for Artrya's proprietary, Salix&r
- 김갑성 기자
- 2025-08-21 19:43
-
FNZ reaches record milestone of US$2 trillion in Assets on Platform
[ 메디채널 황정호 기자 ] Assets on Platform have grown by 406% over the last five years This milestone reinforces FNZ's position as one of the world's largest wealth management platforms FNZ now partners with over 650 financial institutions, more than 12,000 wealth management firms and serves over 26 million end investors globally 6 out of the top 10 most recommended UK adviser platforms use FNZ technology, according to recent analysis conducted by Defaqto Builds on FNZ's purpose to open up wealth by making wealth management more accessible and personalized to more people LONDON and
- 황정호 기자
- 2025-08-21 19:33
-
Transforming Entertainment Experience with AI: iQIYI's iJump Feature Surpasses 150 Million Interactions in 120 Days
BEIJING, Aug. 21, 2025 -- On August 21, iQIYI, China's leading online entertainment platform, proudly announced a major milestone for its groundbreaking AI-powered feature, iJump. Since launching on April 21, 2024, iJump has recorded over 150 million user interactions within just 120 days, signaling rapid adoption and a fresh way viewers are engaging with long-form content. iJump was created in response to evolving viewer preferences, this innovative tool allows users to effortlessly jump between key scenes and story highlights. Powered by sophisticated AI, iJump
- 김장윤(JASON KIM) 기자
- 2025-08-21 18:49
-
Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results
Multiple Ongoing Phase 2b Studies Advancing HBV Functional Cure Strategy Greater China Partnership with Joincare to Accelerate Development of Critical Care Antibiotic soralimixin Strong Cash Position to Pursue New Discovery Opportunities and Partnership Strategy Conference Calls Scheduled: English Session: August 21 at 9:00 p.m. HKT / 9:00 a.m. ET Chinese Session: August 22 at 9:00 a.m. HKT / August 21 at 9:00 p.m. ET DURHAM, N.C., and BEIJING, Aug. 21, 2025 -- Brii Biosciences Limited ("Brii Bio," or the "Company," stock code: 2137.HK),
- 김갑성 기자
- 2025-08-21 18:02
-
BeeWeave Announces Launch of Equity Incentive Management System, Prepares for Nasdaq Listing
BEIJING, Aug. 21, 2025 -- On August 20, Beijing Bee Weaving Network Technology Co., Ltd. ("Bee Weaving") announced the official launch of its Equity Incentive Management System, marking a key milestone in the company's long-term capitalization strategy. The initiative is designed to drive business expansion and technological innovation through a dual focus on talent incentives and capital deployment, strengthening Bee Weaving's leadership position in the biotech and AI sectors. Bee Weaving has also begun preparations for an RTO (Reverse Takeover) asset restructuring, with the
- 황정호 기자
- 2025-08-21 18:02
-
SINGZYME WINS 2025 AMGEN X NSG GOLDEN TICKET FOR BREAKTHROUGH BIOCONJUGATION PLATFORM
[ 메디채널 김갑성 기자 ] Now in its fourth year, the programme continues to empower biotech startups through ecosystem support and collaboration to advance science that serves patients. SINGAPORE, Aug. 21, 2025 -- Singzyme, a Singapore-based biotech startup pioneering next-generation bioconjugation solutions, has been named the winner of the 2025 Golden Ticket Programme in Singapore. The award is part of a joint programme by Amgen, a U.S.-based leader in biologic medicines and NSG BioLabs, Singapore's leading provider of biotechnology co-working laboratories and offices. Now in
- 김갑성 기자
- 2025-08-21 17:38
-
The Business Show Asia 2025 Set to Inspire, Connect, and Transform Businesses
SINGAPORE, Aug. 21, 2025 -- Building on the remarkable success of The Business Show Asia 2024, we are delighted to announce its prestigious return to Singapore. Join us on the 27th and 28th of August as Asia's foremost business event unfolds at the world-class Sands Expo & Convention Centre, Marina Bay Sands. Following a highly successful 2024 edition at the Sands Expo, where over 8,000 business leaders gathered to connect, learn and grow, we are proud to return with this distinguished event once again. The Business Show Asia will continue to serve as a premier platform for
- 황정호 기자
- 2025-08-21 16:00
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-09-06_SAT
2025-09-05_FRI
- TECNO Wins Three Global Product Innovation Technology Awards at IFA 2025 for TECNO Slim, MEGABOOK S14, and AI Glasses Series 23:00
- Huadong Medicine Announces Positive Preliminary Results from a Phase Ⅰ study of HDM2005, a ROR1-Targeting ADC 21:38
- Hanvon Ugee Shines at IFA 2025, Showcasing Global Innovations in Digital Drawing and Writing Solutions 21:26
- NYSE Content Advisory: Pre-Market Update + e.l.f. Beauty celebrates $1 billion acquisition of Hailey Bieber's rhode brand 21:00
- CGS International Securities Singapore Democratizes Access to Capital Markets with ViewTrade's Solutions 20:52
- 'CART BP pro' Opens a New Paradigm in Blood Pressure Management, Maintaining Accuracy Across Arm Positions 20:48
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 09월 06일 03시 40분